Jean F. Voltaire

Array ( [id] => 7200189 [patent_doc_number] => 20050164976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Combination of a cdk inhibitor and 5-fu for the tratment of cancer' [patent_app_type] => utility [patent_app_number] => 10/507883 [patent_app_country] => US [patent_app_date] => 2003-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8262 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164976.pdf [firstpage_image] =>[orig_patent_app_number] => 10507883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5866100 [patent_doc_number] => 20060100231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Amorphous clopidogrel hydrogen sulfate' [patent_app_type] => utility [patent_app_number] => 10/433210 [patent_app_country] => US [patent_app_date] => 2003-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 984 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100231.pdf [firstpage_image] =>[orig_patent_app_number] => 10433210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822238 [patent_doc_number] => 20030220399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes, hyperlipidemia and hyperuricemia' [patent_app_type] => new [patent_app_number] => 10/382186 [patent_app_country] => US [patent_app_date] => 2003-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 24383 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220399.pdf [firstpage_image] =>[orig_patent_app_number] => 10382186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7402089 [patent_doc_number] => 20040019088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Use of Epothilones in the treatment of brain diseases associated with proliferative processes' [patent_app_type] => new [patent_app_number] => 10/375043 [patent_app_country] => US [patent_app_date] => 2003-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7013 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20040019088.pdf [firstpage_image] =>[orig_patent_app_number] => 10375043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6966055 [patent_doc_number] => 20050232952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Self emulsifying drug delivery systems for poorly soluble drugs' [patent_app_type] => utility [patent_app_number] => 10/507857 [patent_app_country] => US [patent_app_date] => 2003-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6605 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20050232952.pdf [firstpage_image] =>[orig_patent_app_number] => 10507857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6835211 [patent_doc_number] => 20030162757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Method of treating alopecia' [patent_app_type] => new [patent_app_number] => 10/376991 [patent_app_country] => US [patent_app_date] => 2003-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 5449 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162757.pdf [firstpage_image] =>[orig_patent_app_number] => 10376991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6706859 [patent_doc_number] => 20030153593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Use of CCI-779 as an antineoplastic agent' [patent_app_type] => new [patent_app_number] => 10/374644 [patent_app_country] => US [patent_app_date] => 2003-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2865 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153593.pdf [firstpage_image] =>[orig_patent_app_number] => 10374644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7193457 [patent_doc_number] => 20050163835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative' [patent_app_type] => utility [patent_app_number] => 10/505231 [patent_app_country] => US [patent_app_date] => 2003-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13055 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20050163835.pdf [firstpage_image] =>[orig_patent_app_number] => 10505231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7138607 [patent_doc_number] => 20050182128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Use of anethole dithiolethione in lung cancer chemoprevention' [patent_app_type] => utility [patent_app_number] => 10/504636 [patent_app_country] => US [patent_app_date] => 2003-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7190 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20050182128.pdf [firstpage_image] =>[orig_patent_app_number] => 10504636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7169490 [patent_doc_number] => 20040077651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Remedies for cancer' [patent_app_type] => new [patent_app_number] => 10/312451 [patent_app_country] => US [patent_app_date] => 2002-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11926 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077651.pdf [firstpage_image] =>[orig_patent_app_number] => 10312451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7362890 [patent_doc_number] => 20040005365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Carcinostatic substance for compatible administration, process of administrating same and process of rapidly inspecting same' [patent_app_type] => new [patent_app_number] => 10/321690 [patent_app_country] => US [patent_app_date] => 2002-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8861 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005365.pdf [firstpage_image] =>[orig_patent_app_number] => 10321690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7026961 [patent_doc_number] => 20050020647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Compositions comprising epothilones and their use for the treatment of carcinoid syndrome' [patent_app_type] => utility [patent_app_number] => 10/498069 [patent_app_country] => US [patent_app_date] => 2002-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4283 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020647.pdf [firstpage_image] =>[orig_patent_app_number] => 10498069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6835181 [patent_doc_number] => 20030162727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Use of cyp1b1inhibitors for treating cancer' [patent_app_type] => new [patent_app_number] => 10/203484 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8720 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162727.pdf [firstpage_image] =>[orig_patent_app_number] => 10203484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6729641 [patent_doc_number] => 20030185831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Methods of treating cancer using an FPT inhibitor and antineoplastic' [patent_app_type] => new [patent_app_number] => 10/303259 [patent_app_country] => US [patent_app_date] => 2002-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11000 [patent_no_of_claims] => 89 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20030185831.pdf [firstpage_image] =>[orig_patent_app_number] => 10303259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801693 [patent_doc_number] => 20030096858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Aralkyl ester soft drugs' [patent_app_type] => new [patent_app_number] => 10/298879 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6652 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096858.pdf [firstpage_image] =>[orig_patent_app_number] => 10298879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6809596 [patent_doc_number] => 20030199535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent' [patent_app_type] => new [patent_app_number] => 10/292823 [patent_app_country] => US [patent_app_date] => 2002-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19940 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20030199535.pdf [firstpage_image] =>[orig_patent_app_number] => 10292823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7145955 [patent_doc_number] => 20050119323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Anticancer agents' [patent_app_type] => utility [patent_app_number] => 10/495217 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 22875 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119323.pdf [firstpage_image] =>[orig_patent_app_number] => 10495217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 868639 [patent_doc_number] => 07365060 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-29 [patent_title] => 'Dinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment' [patent_app_type] => utility [patent_app_number] => 10/492196 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6192 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/365/07365060.pdf [firstpage_image] =>[orig_patent_app_number] => 10492196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7145654 [patent_doc_number] => 20050119263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Treatment of breast cancer' [patent_app_type] => utility [patent_app_number] => 10/494961 [patent_app_country] => US [patent_app_date] => 2002-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4645 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119263.pdf [firstpage_image] =>[orig_patent_app_number] => 10494961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034389 [patent_doc_number] => 20050032899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination' [patent_app_type] => utility [patent_app_number] => 10/494221 [patent_app_country] => US [patent_app_date] => 2002-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12929 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032899.pdf [firstpage_image] =>[orig_patent_app_number] => 10494221 [rel_patent_id] =>[rel_patent_doc_number] =>)